Skip to main content
. 2023 Sep 28;19:2039–2054. doi: 10.2147/NDT.S424017

Table 1.

Neurocognitive Recovery in Abstinent AUD Patients: Factors and Evidence

Domain Factors
Drinking related Smoking A 9b 11b 20b 21b 26c 28a
NA 22b 30b
Quantities used A 29b 15c
NA 9b 21b 30b 6b 2a 10c 3b 20b 13c 28a 31a
Polysubstance A 26c
NA 4b 21b 13c
Detoxifications A 17b
NA 6b 31a
Positive family history A 2a 4b 5b
NA 8b 31a
Demographic Age A 2a 15c 21b 20b
NA 4b 9b 22b 31a 8b 30b
Gender A
NA 2a 7 c 31a
Education A 4b
NA 2a 15c 9b 21b 28a
Psychiatric Depression A 2a 20b
NA 3b 21b 28a 8b 31a
ASPD* A 2a 4b
NA
Premorbid cognitive functioning Verbal reading A 20b
NA 9b 21b 22b 3b
Neurocognitive task A 2a
NA
Medical Blood values A 7c 1c 2a
NA
Medical conditions A 4b
NA 21b 28a
Brain volumes A 12b 23b 11b 22b 10c
NA 10c
Perfusion A
NA 14b

Notes: Numbers refers to the study that did, or did not, found an association or effect (<.05) of the specific factor on neurocognitive recovery: 149, 239, 315, 443 545, 637, 747, 846, 934, 1038, 1132, 1252, 1340, 1453, 1517, 1694, 1744, 1896, (no factors), 1948, 2028, 2131, 2235, 2351, 2495, (no factors), 2512, 2633, 2797, 2829, 2942, 3036, 3141. Indication of level of evidence according to Oxford Classification for Evidence Based Medicine (OCEBM), varying from 1 (very strong) to 5 (very weak): aLevel 2, bLevel 3, cLevel 4. *Antisocial Personality Disorder.

Abbreviations: A, associated; NA, not associated.